SafeLine self-hosted WAF blocks SaaS bot abuse with 99.45% accuracy, cutting fake sign-ups and stabilizing CPU usage.

An RTAF T-50 with decals marking bomb drops. Credit: Royal Thai Air Force SEOUL—The South Korean government is reportedly reviewing approval of additional T-50TH advanced trainer exports to Thailand ...

The term "GPS" has become ubiquitous in American life. You know it as the foundational technology of navigation apps like Google Maps and Waze, but in most of the world, GPS is just a meaningless trio ...

TOKYO—Imagine a sheet made of microscopic glass fibers, woven by a former silk maker and thinner than a human hair. A shortage of this material—essential in artificial-intelligence chips—is looming ...

Rei is the Deputy Lead for GameRant's Anime Team from Kashmir, situated in Beirut. He's an avid fan of anime and manga. Rei grew up watching anime and had a knack for writing ever since he was a kid, ...

Apple reported blowout first-quarter earnings on Thursday, and predicted growth of as much as 16% in the current quarter, matching the period that just ended. Sales could be even better, Apple said, ...

The big AI companies promised us that 2025 would be “the year of the AI agents.” It turned out to be the year of talking about AI agents, and kicking the can for that transformational moment to 2026 ...

Advanced Micro Devices is rated a hold due to a lack of a competitive MOAT and lagging AI accelerator performance versus NVDA. AMD's revenue and earnings are expected to grow 20–30% YoY, but market ...

If you’ve ever had a hernia, it may seem like a harmless bulge in your abdomen or groin. However, if left untreated, a hernia can get larger as time passes and cause pain and further medical ...

Eureka Therapeutics, Inc., a clinical-stage biotechnology company advancing next-generation T-cell therapies for cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — An in vivo chimeric antigen receptor T-cell therapy administered without lymphodepletion exhibited ...